Literature DB >> 3056695

The optimum management of arthropathies.

C S Wolfe1, G R Hughes.   

Abstract

The aims in management of an arthropathy are to relieve symptoms, preserve function, and control the disease process. Drugs are an important, although not the only, part of any therapeutic regimen enabling us to achieve these aims. Although each individual requires a unique strategy, there is a logical progression from first-line agents to second-line agents. Third-line agents and experimental methods are reserved for aggressive or life-threatening disease. The choice of agent in each group is personal preference, but many agents have high adverse effect profiles, and close monitoring is essential.

Entities:  

Mesh:

Year:  1988        PMID: 3056695     DOI: 10.2165/00003495-198836030-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  64 in total

1.  A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. A second report by the joint committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatic diseases.

Authors: 
Journal:  Ann Rheum Dis       Date:  1960-12       Impact factor: 19.103

2.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

3.  Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

4.  Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.

Authors: 
Journal:  Lancet       Date:  1973-02-10       Impact factor: 79.321

Review 5.  Disease-modifying drugs for progressive rheumatoid arthritis.

Authors:  T W Bunch; J D O'Duffy
Journal:  Mayo Clin Proc       Date:  1980-03       Impact factor: 7.616

6.  Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis.

Authors:  D E Trentham; J A Belli; R J Anderson; J A Buckley; E J Goetzl; J R David; K F Austen
Journal:  N Engl J Med       Date:  1981-10-22       Impact factor: 91.245

7.  The co-occurrence of Reiter's syndrome and acquired immunodeficiency.

Authors:  R Winchester; D H Bernstein; H D Fischer; R Enlow; G Solomon
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

8.  Azathioprine in rheumatoid arthritis.

Authors:  M Mason; H L Currey; C G Barnes; J F Dunne; B L Hazleman; I D Strickland
Journal:  Br Med J       Date:  1969-02-15

9.  Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Authors:  V C Neumann; K A Grindulis; S Hubball; B McConkey; V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

10.  Methotrexate in Reiter's disease.

Authors:  E T Owen; M L Cohen
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.